Premature Ovarian Insufficiency in a Patient With Vogt–Koyanagi–Harada Syndrome: An Unusual Association—A Case Report
Authors:
- Ruan Barboza RochaRRRuan Barboza Rocha
- Denise Corrêa BenzaquemDBDenise Corrêa Benzaquem
- Paloma de Sousa PassosPPPaloma de Sousa Passos
- Evellyn Karine Cruz da SilvaESEvellyn Karine Cruz da Silva
- Jadiele Barbosa MendonçaJMJadiele Barbosa Mendonça
- Paula Rita Leite da SilvaPSPaula Rita Leite da Silva
- Jorge Frank Braga FerreiraJFJorge Frank Braga Ferreira
- Cleiton FantinCFCleiton Fantin
Open Access
- 1 January 2026
- journal article
- case report
- Published by Wiley in Case Reports in Medicine
- Vol. 2026 (1) , 2727070
Abstract
Premature ovarian insufficiency (POI) is a clinical syndrome characterized by ovarian failure in women of reproductive age before the age of 40 years. Its main manifestations include menstrual cycle disturbances, such as oligomenorrhea or amenorrhea. The etiology of POI is highly heterogeneous, with a particular emphasis on genetic and immunological factors. In addition, the condition may be associated with other rare diseases, such as Vogt–Koyanagi–Harada (VKH) syndrome. Our study aimed to describe a rare clinical case of a patient from Manaus, Amazonas, Brazil, who was simultaneously diagnosed with two rare conditions: POI and VKH syndrome, with a specific focus on their etiological characteristics, clinical manifestations, and laboratory findings. Clinical data were collected from the patient’s medical record, as registered in the outpatient clinic database at Araújo Lima Hospital. Case description: The case involves a 38‐year‐old, nulliparous, mixed‐race, married female patient diagnosed with POI and VKH syndrome. The understanding of these rare syndromes and the search for an integrated approach are fundamental to ensure better clinical outcomes, quality of life, and reproductive planning for affected patients. This report provides relevant information on the association between two rare syndromes, with the aim of contributing to medical decision‐making and diagnostic clarification, as well as providing guidance on appropriate multidisciplinary follow‐up. Thus, early diagnosis and appropriate treatment are essential steps in promoting this patient’s health.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado do Amazonas
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 39 references indexed in Scilit:
- Classification Criteria for Vogt-Koyanagi-Harada DiseaseAmerican Journal of Ophthalmology, 2021
- Insights into the autoimmune aspect of premature ovarian insufficiencyBest Practice & Research Clinical Endocrinology & Metabolism, 2019
- Premature ovarian insufficiency (POI) and autoimmunity-an update appraisalJournal of Assisted Reproduction and Genetics, 2019
- Catching the therapeutic window of opportunity in early initial-onset Vogt–Koyanagi–Harada uveitis can cure the diseaseInternational Ophthalmology, 2018
- Reappraisal of the management of Vogt–Koyanagi–Harada disease: sunset glow fundus is no more a fatalityInternational Ophthalmology, 2016
- Premature ovarian insufficiency: the context of long-term effectsJournal of Endocrinological Investigation, 2016
- High rate of clinical recurrence in patients with Vogt–Koyanagi–Harada disease treated with early high-dose corticosteroidsGraefe's Archive for Clinical and Experimental Ophthalmology, 2015
- An update on primary ovarian insufficiencyScience China Life Sciences, 2012
- Vogt–Koyanagi–Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and JapanInternational Ophthalmology, 2007
- Chromosome preparations of leukocytes cultured from human peripheral bloodExperimental Cell Research, 1960